about
Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.Variability in spine radiosurgery treatment planning - results of an international multi-institutional study.Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis.Miniature scintillating detector for small field radiation therapy.Cone-beam-CT guided radiation therapy: technical implementation.Reirradiation human spinal cord tolerance for stereotactic body radiotherapy.Online planning and delivery technique for radiotherapy of spinal metastases using cone-beam CT: image quality and system performance.Integral test phantom for dosimetric quality assurance of image guided and intensity modulated stereotactic radiotherapy.Lack of influence of intravenous contrast on head and neck IMRT dose distributions.Semiautomatic vertebrae visualization, detection, and identification for online palliative radiotherapy of bone metastases of the spine.Advances in technology for intracranial stereotactic radiosurgery.Multicenter collaborative quality assurance program for the province of Ontario, Canada: first-year results.Surgical resection of epidural disease improves local control following postoperative spine stereotactic body radiotherapy.Technique for stereotactic body radiotherapy for spinal metastases.Stereotactic body radiotherapy is an effective treatment in reirradiating spinal metastases: current status and practical considerations for safe practice.Stereotactic body radiotherapy: a new paradigm in the management of spinal metastases.Risk for surgical complications after previous stereotactic body radiotherapy of the spine.Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases.Multileaf collimator performance monitoring and improvement using semiautomated quality control testing and statistical process control.Magnetic resonance imaging assessment of spinal cord and cauda equina motion in supine patients with spinal metastases planned for spine stereotactic body radiation therapy.Apparatus-dependent dosimetric differences in spine stereotactic body radiotherapy.Strategic planning in an academic radiation medicine program.Cone-beam-CT guided radiation therapy: A model for on-line application.Patterns of epidural progression following postoperative spine stereotactic body radiotherapy: implications for clinical target volume delineation.Automated planning of tangential breast intensity-modulated radiotherapy using heuristic optimization.Evaluation of a 2D diode array for IMRT quality assurance.Spatial and volumetric changes of retroperitoneal sarcomas during pre-operative radiotherapy.Quality Control Methods for Linear Accelerator Radiation and Mechanical Axes Alignment.Prospective comparison of clinical and computed tomography assessment in detecting uterine perforation with intracavitary brachytherapy for carcinoma of the cervix.Vertebral Compression Fracture (VCF) After Spine Stereotactic Body Radiation Therapy (SBRT): Analysis of Predictive FactorsThe Canadian Association of Radiation Oncology Scope of Practice Guidelines for Lung, Liver and Spine Stereotactic Body RadiotherapyA One-Step Cone-Beam CT-Enabled Planning-to-Treatment Model for Palliative Radiotherapy-From Development to ImplementationImpact of Immobilization on Intrafraction Motion for Spine Stereotactic Body Radiotherapy Using Cone Beam Computed TomographySU-E-T-94: Multileaf Collimator Performance and Validation of Quality Control TolerancesCase report: grade 4 radiation-induced colitis following conventional reirradiation to a hip metastasisTreatment planning and delivery evaluation of volumetric modulated arc therapy for stereotactic body radiotherapy of spinal tumours: impact of arc discretization in planning system
P50
Q30275557-190D14A8-6697-437B-952C-BB3F2EEC669DQ30276965-2B71709D-E4A3-4EF7-B4BE-6DBFED69A21EQ30303090-073E46B6-D995-415A-A08C-2C357866E12AQ33179392-FB4A19BC-B87B-4FF6-B2ED-E383D3C660C5Q33214977-CE518FAB-79D8-4449-8FAF-9760DA67A9F1Q33273932-4A2D6555-9A34-4884-8FF5-CCBCF4432BBDQ33276734-2B59B9C6-A37E-46EF-B26E-23365B465619Q33287031-3A178459-A884-44B4-8E57-C7AB89FDB738Q33302524-4E777FF4-628F-4DA5-9D53-3B8C239F79CCQ33320850-E0B056AB-09A1-4C13-9418-C766E4427D11Q33488966-9A971558-3A72-4386-8DEC-A926F4B0AC0FQ34609372-C0AA181B-BA10-4EB7-84FD-9916F096F637Q37187719-38A1F2AF-347C-4543-9819-2CAD3FAC34CAQ37819416-06EF12A8-53AF-4B54-9367-032F6571B607Q37960918-10C6AC38-3151-49EA-A148-EB710D0FAD6DQ38233104-8B3933BE-BFE6-46ED-BE13-42A3D7F537C2Q41281860-977EB2E7-7036-4328-B297-3AB3D651E815Q41348619-F8D32C40-F38B-4599-86F5-6F7CE692EB32Q41730348-7B83A247-6670-4D9B-87E1-4396F0E6A1BCQ46470290-7234953E-66B7-44A1-9C13-0288EF92058DQ46695575-751D013C-771E-4818-8BC2-BBDBA37C8EEBQ47094620-567D71C2-6BD6-49AB-BA2E-221FC60CE94CQ48888476-6BFEA6D7-6F75-4A94-863C-6A1F4B0D6042Q48898412-10C6B186-74C9-48DE-A6B6-DA4EA9DD0EEDQ51612945-869C1B3B-3823-4FC5-9FA6-D666CF1A3BDFQ51700568-F9B89527-3066-4B0E-91C8-9C64922F75F0Q51702202-CF994054-C484-4238-90A1-7E65C34B7138Q52323950-D819CEE3-5BE3-4A5D-9178-2C54DD96DEBFQ53494594-3640E1F2-AC66-4496-8CF9-1C5394D94851Q57839147-E5E1E8B9-EE17-48F7-A6AF-7345D8183FA5Q61771667-C9A596F1-5ED7-436C-B4A9-4377956FF968Q61902111-1BCFD540-FDCA-46B3-819D-2A69496561ACQ61902119-6BE19923-2489-4448-AC02-450EC0B154CAQ61902135-3DFBFD41-DAAF-4682-9446-F99B7B73F88FQ83490685-54F8077E-C220-4F09-8F1F-25B8B7F9B5BAQ84408826-1D5FF684-55F1-4D69-A07A-501C0477E0BA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Daniel Létourneau
@ast
Daniel Létourneau
@en
Daniel Létourneau
@es
Daniel Létourneau
@nl
Daniel Létourneau
@sl
type
label
Daniel Létourneau
@ast
Daniel Létourneau
@en
Daniel Létourneau
@es
Daniel Létourneau
@nl
Daniel Létourneau
@sl
prefLabel
Daniel Létourneau
@ast
Daniel Létourneau
@en
Daniel Létourneau
@es
Daniel Létourneau
@nl
Daniel Létourneau
@sl
P106
P1153
8642559800
P21
P31
P496
0000-0002-7130-0487